CatherineMBroomeMD
Hematology • Washington, DCClotting Disorder, Hemophilia & Bleeding Disorder
Associate Professor, Medicine, Georgetown University School of Medicine
Dr. Broome is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3700 Reservoir Rd
Lombardi Cancer Center Podium D
Washington, DC 20007
Clinical Expertise
- Hematologic oncology, Autoimmune hemolytic anemia, Complement deficiencies, Immune thrombocytopenic purpura, Hemolytic-uremic syndrome, Bleeding disorders, Anemia
Education & Training
George Washington UniversityFellowship, Hematology and Medical Oncology, 1988 - 1991
Prisma Health/University of South Carolina SOM Greenville (Greenville)Residency, Internal Medicine, 1985 - 1988
LSU School of Medicine in ShreveportClass of 1985
Certifications & Licensure
DC State Medical License 1989 - 2024
VA State Medical License 1993 - 2022
MD State Medical License 2010 - 2020
SC State Medical License 1986 - 1993
LA State Medical License 1985 - 1989- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013
Publications & Presentations
PubMed
- 2 citationsEfgartigimod alfa for the treatment of primary immune thrombocytopenia.Catherine Broome
Therapeutic Advances in Hematology. 2023-01-01 - 255 citationsDiagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus MeetingUlrich Jäger, Wilma Barcellini, Catherine Broome, Morie A. Gertz, Anita Hill
Blood Reviews. 2020-05-01 - 18 citationsComplement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results.Alexander Roth, Wilma Barcellini, Shirley D'Sa, Yoshitaka Miyakawa, Catherine M Broome
Haematologica. 2022-07-01
Press Mentions
Researchers Find Drug Effective to Treat Autoimmune Blood DisorderDecember 12th, 2022- After One Week, Efgartigimod Helps 38% of ITP Patients Achieve Platelet Counts to Avoid BleedingDecember 11th, 2022
- Drug Found to Be Effective in Difficult to Treat Autoimmune Blood DisorderDecember 10th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
